. The design and development of LRRK2 inhibitors as novel therapeutics for Parkinson's disease. Future Med Chem. 2024 Dec 24;:1-16. Epub 2024 Dec 24 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.